Tagged: Department of Bioengineering and Therapeutic Sciences

FDA, academia, and industry join forces to shepherd new therapies to patients

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

Modulation of Innate Immunity by Arboviruses; Beyond the STING: a QBI seminar with Ana Sesma

The QBI Seminar Series is presenting Ana Sesma, professor with tenure in the department of Microbiology at Icahn School of Medicine at Mount Sinai. She is interested on the modulation of innate immunity by viruses of human health interests, such as dengue, influenza, human immunodeficiency virus...

Genomics Characterization and Surveillance of Microbial Threats in West Africa: a QBI seminar with Christian Happi

The Infectious Disease and Human Health Seminar Series is presenting a Seminar with Christian Happi. Dr. Happi is the Director of the World Bank-funded African Center of Excellence for Genomics of Infectious Disease (ACEGID), Professor of Molecular Biology and Genomics, and the former Dean of the...

Quantitative Biology of the Cancer Cell Symposium

Co-organized by Drs. Davide Ruggero and Sourav Bandyopadhyay of UC San Francisco, the inaugural Quantitative Biology of the Cancer Cell Symposium will be held on campus at the University of California, San Francisco on February 24-25, 2020. Under the leadership of Dr.

QBI Signaling Across Scales Symposium

Organized by Natalia Jura of UCSF, Pedro Beltrao of EMBL and Nevan Krogan of UCSF and Gladstone Institutes, the Signaling Across Scales Symposium will focus on the current understanding of cell signaling from atomic resolution structures to network regulation with the emphasis on spatial...

Elizabeth Daniels Fund underscores the importance of community

In permanent recognition of Elizabeth Daniels’ decades-long commitment to nurturing an inclusive UCSF School of Pharmacy community, a gift of $1 million to the UCSF Foundation by Troy Daniels, DDS, and Leslie Daniels, established the endowed Elizabeth Daniels Fund, in December 2019, to support...

Pharmacists uniquely poised to reduce unnecessary prescriptions

UCSF School of Pharmacy Dean B. Joseph Guglielmo, PharmD, argues that pharmacists can help reduce the use of unnecessary medications.

Rare cystic fibrosis mutations limit the benefits of targeted drugs

Mutations leading to cystic fibrosis in Latino patients may create treatment disparities, say School scientists

Desai and Szoka named fellows of the National Academy of Inventors

The two faculty members have spent their careers working to improve therapies to treat disease.

Update from the Dean – November 2019

Dear UCSF School of Pharmacy Family and Friends: